The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette).
作者信息
Byfield P E, Barth C L, Brodie J A, Cosimi A B, Dienst S G, Elberg A J, Elfring G L, Hardy M A, Hayashi H, Kountz S L, Lamborn K R, Loughman B E, Sakai A, Satoh P S, Zielinski C M, Wechter W J
出版信息
Transplant Proc. 1978 Sep;10(3):627-31.
PMID:362648
Abstract
摘要
相似文献
1
The use of circulating rosette-forming cells as a guide to determination of ATG dose (dose-by-rosette).使用循环玫瑰花结形成细胞作为确定抗胸腺细胞球蛋白剂量（按玫瑰花结计算剂量）的指导。
Transplant Proc. 1978 Sep;10(3):627-31.
2
Individualized management of immunosuppression according to serial monitoring of immunocompetence.根据免疫能力的连续监测进行个体化免疫抑制管理。
Transplant Proc. 1978 Sep;10(3):647-50.
3
Pretransplant T cell levels and renal allograft survival.移植前T细胞水平与肾移植存活率
Proc Eur Dial Transplant Assoc. 1979;16:449-53.
4
Antithymocyte globulin (ATG) dosage and graft survival in renal transplantation.抗胸腺细胞球蛋白（ATG）剂量与肾移植中的移植物存活情况
Transplant Proc. 1977 Mar;9(1):1023-5.
5
6
7
Changes in peripheral blood T-cell rosettes in kidney allograft patients during the first postoperative month.
Am Surg. 1980 Dec;46(12):697-707.
8
Does suppression of T-RFC determine in vivo immunosuppressive effect of ATG?T调节性玫瑰花结形成细胞（T-RFC）的抑制作用是否决定了抗胸腺细胞球蛋白（ATG）的体内免疫抑制效果？
Transplant Proc. 1979 Jun;11(2):1433-4.
9
Prolonged allograft survival of strong pretransplant immune responders treated with ATG.接受抗胸腺细胞球蛋白治疗的移植前免疫反应强烈者同种异体移植物长期存活。
Transplant Proc. 1981 Mar;13(1 Pt 1):332-5.
10
In vivo - in vitro correlates of antithymocyte globulin (ATG) immunosuppression in the human.
Proc Clin Dial Transplant Forum. 1978;8:56-61.
Zotero 插件